Drug Information Association announces 39th Annual Meeting
HORSHAM, PA., May 14, 2003 The Drug Information Association (DIA) will hold its 39th Annual Meeting June 15 19, at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
Highlights for this year's meeting will include two new features: "Ask the Regulators" and "Ask the Industry Experts."
"Ask the Regulators" will allow DIA members to jointly discuss regulatory issues with Thomas Lönngren, Executive Director, European Medicines Evaluation Agency (EMEA), UK, and with Mark B. McLellan, the newly appointed US FDA Commissioner. The "Breakfast with the Industry Experts" offers a distinguished international panel which will discuss industry challenges presented by current regulatory and economic conditions.
The annual meeting is conceived, developed, and conducted by its volunteer members to educate their colleagues. "It is the members' dedication to educate colleagues that is the driving force behind all DIA programs," explains Robert Assenzo, PhD, DIA executive director. "We have an open approach to content planning that is directly related to the issues our members face in their jobs. This is what sets DIA apart from other groups and makes our programs so successful." -more-
Murray M. Lumpkin, MD, MSc, will serve as the 2003 Annual Meeting Chairperson. He currently serves as Principle Associate Commissioner of the US Food and Drug Administration where his duties also include overseeing FDA Office of International Programs, Office of Pediatric Therapeutics, and Office of Combination Products.
Dr. Bob Arnot, former NBC Chief Medical Officer and newly appointed NBC Special Foreign Correspondent, will deliver the Keynote Address on Monday, June 16th.
This year's expansive program will include educational tracks organized around 27 interest areas, 35 tutorials, 380 sessions with more than 1,100 speakers, and 480 company exhibits, as well as a plethora of networking and social events, plenary sessions, poster sessions, and special vacation tour packages. Registration information can be found at www.diahome.org or by calling DIA headquarters in at 215-442-6100.
For nearly four decades, DIA has provided professionals involved in the discovery, development, evaluation and utilization of medicines and related health care technologies with professional and career development resources and training to help them deliver effective medicines to patients as quickly and safely as possible. As an organization deeply committed to preserving and protecting the health and well-being of all the world's people, DIA aims to provide everyone involved in this process, from research through marketing, with the most current and accurate information available.
DIA has evolved from a founding group of thirty U.S. professionals employed in academia and the pharmaceutical industry into an international organization which annually holds more than 100 meetings, training courses, and symposia for nearly 30,000 members from the pharmaceutical industry, government regulatory agencies, academic institutions, contract service organizations (CSOs), and other bodies, around the world.
Source: DIA www.diahome.org
Posted: May 2003